RUSNANO Takes Part in International Forum Open Innovations

31 October 2012

October 31, 2012 is the first day of Open Innovations, the Moscow international forum for innovative development. The RUSNANO Group is one of the forum’s organizers.

In the opening day of work, RUSNANO CEO Anatoly Chubais participated in the plenary session of the forum, Global Challenges for Humanity: Demand for Innovation, which followed the official opening. The session was broadcast live via the Internet. Later he presented his views at the session Regional Specifics for Innovative Business.

During the second day of the forum, Mr. Chubais will moderate the panel discussion Can Nanotechnologies Revolutionize Materials?  Finally, on November 2, 2012, he will take part in the plenary session Russian Development Institutions—A Look from the Outside, A Look from the Inside. That session is being devoted to findings from an international study of the effectiveness of Russia’s institutes for development. RUSNANO plans to make several announcements about its projects during the three-day forum.

RUSNANOPRIZE, the international award in nanotechnology, will be presented during the second day of the forum. This year the jury, composed of scientists and entrepreneurial heads of innovative businesses, has chosen Sergey Lukyanov, a member of the Russian Academy of Sciences, as laureate. Dr. Lukyanov is being recognized for the discovery fluorescent proteins of different colors that are in high demand in biotechnology and medicine. Also during the gala ceremony, a new award, Growth Factor, will be made. Established by RUSNANO in 2012, this annual award will go to the state company whose work in introducing and popularizing the use of a nanotechnology product or products has been outstanding.

Along with plenary and special interest sessions, debates and discussions, Open Innovations offers several integrated thematic expositions. For example, innovative projects in prevention, diagnostics, and treatment of illnesses will be addressed in Innovations in Medicine and Pharmaceuticals. Nine of the twelve exhibitions are being presented by RUSNANO portfolio companies: In the area of diagnostics, Erbitech demonstrates its laser-based glucometers, Hemacore shows how it registers thrombodynanics, and PET-Technology presents the work of its PET centers. In prevention, portfolio companies, NTPharma and Selecta  present their advances—nanovaccines and nanopharmaceuticals using pseudo-adenoviral particles and vaccines using the tSVP™ platform, respectively. Therapeutic interventions includes BIND’s Accurins™ platform drugs, mitochondrial antioxidants from Mitotech, cascade filtration of blood plasma from TRACKPORE TECHNOLOGY, and microsources for brachytherapy from BEBIG. As they enter the market, these preparations, instruments, therapeutic methods, and diagnostic advances, will improve the quality of medical services.

Innovations in Medicine and Pharmaceuticals

The forum Open Innovations will give the general public its first glimpse of the Dozor radar-optical surveillance system. Designed and produced by RUSNANO portfolio company ELVEES NeoTech. Dozor is an automatic, 24/7, all-weather system for surveillance and organization of mobile security and intelligence posts. It is based on a unique platform of video analytics that runs on 90-nanometer chips. The swing-frame assembly, which is mounted on a truck, includes an Orwell-R radar location system, a highly thermal imaging device, a long-focal-length video camera, a directional microphone, and a projector. The system transmits real-time information about the objects it identifies (coordinates, type, photographs, and other) to the control center.

Dozor radar-optical surveillance system

Additional information

Reference

RUSNANO Joint-Stock Company was founded in March 2011 through reorganization of state corporation Russian Corporation of Nanotechnologies. JSC RUSNANO contributes to implementation of the state policy on the development of the nanotechnology industry by investing directly and through investment funds of nanotechnology in financially effective high-technology projects providing the development of new production facilities in the Russian Federation. Its primary investment focus is in electronics, optoelectronics and telecommunications, healthcare and biotechnology, metallurgy and metalwork, energy, mechanical engineering and instrument making, construction and industrial materials, chemicals and petrochemicals. 100 percent of shares of JSC RUSNANO are owned by the state. Thanks to investments RUSNANO currently opened 73 factories and R&D centers in 28 regions of Russia.

Management of assets of RUSNANO JSC is carried out by Limited Liability Company established in December 2013, RUSNANO Management Company. Anatoly Chubais is the Chairman of its Executive Board.

Work to establish nanotechnology infrastructure and carry out educational programs is fulfilled by RUSNANO’s Fund for Infrastructure and Educational Programs, which was also established during the reorganization of the Russian Corporation of Nanotechnologies.